The polymorphism of bumetanide, of glibornuride and of chlorpromazine picrate
Borka, L.
Acta Pharmaceutica Suecica 14(2): 205-209
1977
ISSN/ISBN: 0001-6675 PMID: 143868 Document Number: 111593
The polymorphism of bumetanide Chlorpromazine normally yields an orange colored picrate (m.p. between 175-179 .degree. C). A lower melting, red-brown modification (m.p. 157-158.degree. C) which changes its color upon transformation into the stable form is described.
Document emailed within 1 workday
Related Documents
Sigurd, B.; Leth, A.; Steiness, E. 1973: Bumetanide. a comparison between the diuretic effect of bumetanide and furosemide in patients with chronic congestive heart failure Ugeskrift for Laeger 135(9): 466-471Forrest, I.S.; Green, D.E.; Serra, M.T.; Soave, O.A. 1975: Chlorpromazine excretion in chronically dosed primates. I. Occurrence of a previously unreported class of chlorpromazine conjugates Psychopharmacology Communications 1(1): 51-59
Chaudhary, A.K.; Hubbard, J.W.; McKay, G.; Midha, K.K. 1988: Identification of a quaternary ammonium-linked glucuronide of chlorpromazine in the urine of a schizophrenic patient treated with chlorpromazine Drug Metabolism and Disposition: the Biological Fate of Chemicals 16(3): 506-508
Lee, K.C.; Hersey, J.A. 1977: Differential thermal analysis of benzocaine picrate polymorphs Acta Pharmaceutica Suecica 14(2): 213-216
Dubach, U.C.; Korn, A.; Raaflaub, J. 1975: On the multiple-dose kinetics of glibornuride in man Arzneimittel-Forschung 25(12): 1967-1969
Rodríguez-Miñón, J.L.; Herrera Pombo, J.L.; Marrón, J.A. 1971: Clinical experience with RO 6-4563 (Glibornuride) (a new oral hypoglycemic agent) Revista Clinica Espanola 123(5): 439-442
Leubner, H. 1973: Results of a clinical test on the oral antidiabetic agent glibornuride (Ro 6-4563) Wiener Medizinische Wochenschrift 123(17): 277-282
Schmitt, E.W.; Nijssen, J. 1978: Glibornuride--field study on an oral antidiabetic agent. Results of therapy with gluboride in a large number of patients Die Medizinische Welt 29(29-30): 1170-1174
Vasiliades, J. 1976: Reaction of alkaline sodium picrate with creatinine: I. Kinetics and mechanism of formation of the mono-creatinine picric acid complex Clinical Chemistry 22(10): 1664-1671
Humair, L. 1982: Bumetanide in renal insufficiency Schweizerische Medizinische Wochenschrift 112(9): 310-314
Ring-Larsen, H. 1975: Bumetanide in the treatment of hepatic ascites Postgraduate Medical Journal 51(Suppl 6): 77-81
Aggernaes, K.H. 1980: Indomethacin inhibition of bumetanide diuresis Ugeskrift for Laeger 142(11): 691-693
Dahlberg, A.; Fagerberg, S.E. 1976: Antihypertensive effects of bumetanide treatment Lakartidningen 73(44): 3753-3755
Voss, D.; Fuchs, G.; Schneider, D.; Schneider, J. 1972: Effect of the oral antidiabetic agent glibornuride on blood coagulation, blood platelets, and fibrinolysis Arzneimittel-Forschung 22(Suppl 12a): 2219
Johansson, B.W. 1975: Bumetanide--a new potent diuretic for oral and intravenous use Lakartidningen 72(37): 3413-3416
Varricchio, M.; Spiezia, R.; Giugliano, D.; Torella, R.; Giannetti, G. 1980: Clinical evaluation of bumetanide in congestive heart failure Il Farmaco; Edizione Pratica 35(7): 349-357
Reddy, M.M.; Quinton, P.M. 1999: Bumetanide blocks CFTR GCl in the native sweat duct American Journal of Physiology 276(1): C231-C237
Fries, D.; Beroniade, V.; Coy, J.L.; Delavelle, F. 1976: Bumetanide, a new diuretic active during chronic renal failure Pathologie-Biologie 24(6): 435-439
Colli, A.M.; Mascarello, M.; Vignati, G.; Fancini, P. 1982: Clinical use of bumetanide in infants with decompensated heart disease Minerva Pediatrica 34(19): 823-834
Günther, R.; Kersten, L.; Bräunlich, H. 1987: Natriuretic effectiveness of bumetanide in rats with immature kidney function Archives Internationales de Pharmacodynamie et de Therapie 286(1): 171-176